Stocks and InvestingStocks and Investing
Fri, October 7, 2022
Thu, October 6, 2022
Wed, October 5, 2022
Tue, October 4, 2022

Nick Abbott Maintained (ADAP) at Hold with Decreased Target to $1.5 on, Oct 4th, 2022


Published on 2024-10-27 23:11:14 - WOPRAI, Nick Abbott
  Print publication without navigation


Nick Abbott of Wells Fargo, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Decreased Target from $7 to $1.5 on, Oct 4th, 2022.

Nick, nor any peers, have made any analyst calls on ADAP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30